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Abstract
Background: Knowledge of the intrinsic properties of embryonic stem cells is essential before the possibility 
of using these cells for therapeutic purposes becomes a reality. Insertional mutagenesis screens are widely used 
to identify genes sufficient to confer a particular phenotype; however, applications of such approaches are limited 
to mouse models. Thus, there is a need to develop a new DNA transposon system that allows gene discovery 
approaches in stem cells.
Methods: This study was performed to explore the possibility of using the long interspersed nuclear element 1 
(LINE -1) retrotransposon as a gene trap vector to identify genes involved in the maintenance and differentiation of 
mouse embryonic stem cells.
Results: We developed an episomal, nonviral LINE-1 retrotransposon system using the scaffold/matrix 
attachment regions in the backbone of our vector. This gene trap vector harbors a GFP marker whose expression 
occurs only after successful insertional mutagenesis. By utilizing this vector, coupled with GFP expression, we have 
successfully isolated four individual embryonic stem cell clones that display disrupted genes, including two known 
genes. We then confirmed the identity of these genes using an inverse PCR approach and verified their function in 
cell differentiation using shRNAs and undifferentiated markers of embryonic stem cells. 
Conclusions: The ease of using this insertional mutagen and the simplicity of identifying the cells with disrupted 
genes by GFP expression make this LINE-1 vector a promising tool for embryonic stem cell and cancer stem cell 
gene discovery.
Keywords: Gene disruption; Small interference RNA; 
Retrotransposon; Cell differentiation 
Introduction
Embryonic stem (ES) cells offer great hope for the future of medicine 
in such areas as cardiovascular disease, diabetes and Parkinson’s 
disease. Of course, knowledge of the intrinsic properties of ES cells 
must be gained before the possibility of using these cells for therapeutic 
purposes becomes a reality. ES cells possess an unlimited capacity to be 
maintained as self-renewing undifferentiated cells. Their ability to grow 
for prolonged periods of time while maintaining a normal karyotype 
and pluripotency offers the enormous potential of differentiating 
them into any specific cell type of interest by manipulating their 
growth conditions. In vitro, ES cells are maintained in the presence 
of the cytokine leukemia inhibitory factor (LIF) as undifferentiated 
populations [1] that are capable of differentiating into various cell types. 
Upon removal of LIF, the ES cells can be easily induced to differentiate 
into spheroid cell aggregates termed embryoid bodies, recapitulating 
early developmental processes. These ES cell capabilities require the 
selective activation and repression of many genes or networks of 
regulatory genes [2,3]. Our current understanding of the genes that 
regulate the self-renewal and differentiation of stem cells is far from 
complete, and identifying these genes is critical for understanding the 
molecular basis of cell commitment. In addition, several genes known 
to play a role in human leukemogenesis have been identified in mouse 
ES cells, including Notch1, Flt3, Lmo2 and Nf1 [4]. Thus, identifying 
the genes that govern ES cells would provide new insights into proteins 
whose function was previously unknown. 
Loss-of-function genetic screening is a powerful method 
for identifying the genes that are sufficient to confer a particular 
phenotype. A traditional approach for generating loss-of-function 
gene mutations has been the use of N-ethyl-N-nitrosourea (ENU) as 
a mutagen, but finding the causal point mutation in such systems is 
difficult and time consuming. Recently, RNAi has been shown to be 
effective in downregulating gene function; however, this strategy 
is labor intensive and is not a cost-effective approach. Alternatively, 
insertional mutagenesis by a retroviral vector derived from murine 
leukemia virus has proved to be a powerful gene trap method for 
generating loss-of-function mutations in ES cells but requires the 
generation of adult mice for functional analysis [5]. Several groups 
have recently used DNA transposons, such as Sleeping Beauty (SB) 
and Drosophila PiggyBac, for gene trap methods [6,7]. However, one 
limitation of the currently available SB transposons is the necessity of 
co-delivering the SB transposon with transposase-encoding DNA for 
the gene integration event. In addition, low transfer efficiency and a 
lack of sustained transposase expression are problems that have been 
reported to occur during cell culture [8,9]. Although the SB transposon 
is commonly used, other DNA transposons are currently being 
developed for gene discovery approaches. In this study, we explored 
the possibility of using long interspersed nuclear element 1 (LINE-1 or 
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L1 retrotransposon) as a tool to deliver a gene trap in ES cells because 
of its efficient disruption of gene function.
The L1 retrotransposon is an insertional mutagen that is capable 
of inserting its sequence into a gene and disrupting the gene’s function 
in individual cells or whole animals. L1 offers potential advantages 
over the SB and PiggyBac transposons, as L1 performs the random 
disruption of genes at a high frequency of insertion throughout the 
genome [10,11]. In addition, L1 mobilizes itself to a new genomic 
location by a ‘copy and paste’ mechanism, which offers an infinite 
source of insertional mutagens for efficient gene knockout throughout 
the genome. Furthermore, the L1 insertion is stable and permanent 
in all of the progeny of integrated cells, and the inserted sequence 
itself serves as a molecular tag to identify the disrupted gene [12]. 
These inherent features of L1 make it a valuable tool in ES cell gene 
discovery applications. We have created an episomal, nonviral L1 
retrotransposition system using the scaffold/matrix attachment regions 
(S/MARs) in the vector backbone [13] and evaluated its utility in 
identifying genes in mouse ES cells. 
Here, we demonstrate that, by utilizing this vector and coupled 
with GFP expression, we have successfully isolated 4 individual ES cell 
clones out of 50 clones screened that display disrupted genes, including 
one novel gene. We confirmed the identity of all of these genes by an 
inverse PCR method and verified their function in cell differentiation 
using undifferentiated markers of ES cells. The ease of using this 
insertional mutagenesis approach and the simplicity of identifying 
cells with disrupted genes by GFP expression make this L1 system a 
potential tool for ES cell gene discovery. Similar to other systems, this 
vector can also be applied to different kinds of stem cells or cancer stem 
cells to identify the genes that are responsive to certain cell growth 
conditions or involved in cancer development.
Materials and Methods
L1 expression vector
The construction of the S/MAR-based L1 retrotransposition vector 
has been described previously [13]. The vector DNA was amplified in 
E.coli DH10B cells and isolated using an endotoxin-free Maxi prep kit 
(Qiagen). 
ES cell culture and transfection
Mouse ES cells were grown on mitomycin C-treated embryonic 
fibroblast (MEF) cell layers and were cultured in complete knockout 
Dulbecco’s modified Eagle’s medium (Invitrogen) with 4.5 mg/ml 
glucose, 2 mM L-glutamine, 0.1 mM β-mercaptoethanol, 15% FCS 
and 1000 U/ml leukemia inhibitory factor (LIF). The same growth 
medium (without LIF and MEFs) was used to differentiate the ES cells. 
Fresh glutamine was added when the medium was replaced daily. 
ES cell transfection was performed using the Amaxa ES nucleofector 
kit. Briefly, 2x105 ES cells were suspended in 90 µl Nucleofection 
solution and 10 µl Nucleofection solution containing 5 µg L1 vector 
added. This mixture was transferred to an electroporation cuvette and 
electroporated using the A-23 program of the Nucleofector 1 device 
(Amaxa Biosystems). Approximately 500 µl of the pre-warmed medium 
was added to the cuvette, and the ES cells were transferred to a 10-cm 
culture plate containing an MEF feeder layer. Neomycin (G418) was 
added to the medium 24 h after transfection at a final concentration of 
175 µg/ml. The ES cells were subjected to neomycin selection for 7 to 8 
days until colonies approximately 1 mm in diameter appeared.
GFP expression of ES clones
Using fluorescence microscopy, G418-resistant GFP-positive 
colonies were individually picked, partially digested with trypsin and 
transferred to a 24-well plate seeded with MEF feeder layers. After 
growing for 3 days, half of the ES cells derived from each clone were 
frozen as a stock, and the remainder was split into two wells of 24-well 
plates. One portion of the cells was grown in the medium with LIF and 
MEFs, and the other was grown without LIF and MEFs for 5 to 6 days 
until the formation of embryoid bodies. The ES clones that failed to 
differentiate in the absence of LIF and MEFs were harvested for further 
analysis.
PCR analysis of ES cells with retrotransposon insertions
Genomic DNA was isolated from each candidate ES clone using 
a QIAamp DNA kit (Qiagen), and PCR was performed using the 
Geno-5’ (5’-TATTGCCGATCCCCTCAGAAGA-3’) and Geno-3’ 
(5’-CAAGGACGACGGCAACTACAAG-3’) primers to examine 
whether GFP expression was a result of retrotransposed L1 insertion. 
The amplification was performed in 50-µl reactions containing 5 µl 
of 10X PCR buffer with 2.5 mM MgCl2, 1 µl of 10 mM dNTPs, 5 µM 
each primer and 250 ng genomic DNA. After an initial step at 95°C 
for 10 min, 30 cycles of amplification were performed (95°C for 30 s, 
58°C for 15 s and 72°C for 2 min), followed by a final step at 72°C for 
8 min. The amplified products were visualized on a 1.2% agarose gel. 
Genomic DNA from the wild-type ES cells and vector DNA were used 
as negative and positive controls, respectively.
Identification of the integration site by Inverse PCR 
Approximately 1 µg genomic DNA was subjected to SspI 
restriction enzyme digestion at 37°C for 4 h. After heat inactivation, 
the digested DNA was treated with 20 units of T4 DNA ligase (NEB) 
for an overnight self ligation. About 250 ng of the ligation mixture 
was used directly as the DNA template for the inverse PCR reaction. 
The first round of the inverse PCR was performed using the following 
primers for the GFP expression: 5’-CTTGAAGAAGATGGTGCG-3’ 
and 5’-ACAACCACTACCTGAGCACC-3’. We used a 5-µl aliquot 
from the first round of PCR as the template for the second round of 
nested PCR using the primers, 5’-TTGAAGAAGTCGTGCTGC-3’ 
and 5’-AAAGACCCCAACGAGAAGCG-3’. The product was cloned 
directly into the Topo-XL (Invitrogen) vector and sequenced. The 
location of the L1 integration sites and disrupted genes were identified 
using the UCSC mouse genome analysis.
qRT-PCR analysis
Total RNA was isolated using the RNeasy Mini Kit (Qiagen), 
and 1 µg RNA was reverse transcribed using SuperScript III Re-
verse transcriptase (Invitrogen) with an oligo(dT)18 primer. qRCRs 
were performed using SYBR Green with 200 nM for forward and re-
verse primers with the PRISM7700 Sequence Detection System. The 
primers used were as follows: for Tollip, forward 5’- GACGAGTG-
GTATAGCCTGAGTG-3’, reverse 5’- ACACAGTTGGCATCAG-
GACCAC-3’; for Oct4 forward 5’- AACCTTCAGGAGATATG-
CAAATCG-3’, reverse 5’- TTCTCAATGCTAGTTCGCTTTCTCT-3’; 
for Nanog forward 5’ TCTTCCTGGTCCCCACAGTTT-3’, reverse 
5’-GCAAGAATAGTTCTCGGGATGAA-3’; for GAPDH forward 
5’-AGGTCGGTGTGAACGGATTTG-3’, reverse 5’-GGGGTCGTT-
GATGGCAACA-3’. The measured transcript levels were normalized 
to GAPDH. The samples were amplified in triplicates.
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siRNA transfection and validation of mutations
Tollip-specific shRNAs (TGGACTCGTTCTACCTTGA, CTCT-
GCCAAGATACTAGAA, and ATGGTGGTAACAAGCACTT in 
the pSiLv-mU6 vector were purchased from GeneCopoeia (product 
ID:MSH033160). Each shRNA was transfected independently into 
wild-type mouse ES cells using an Amaxa Nucleofector kit as described 
above. The depletion of Tollip mRNAs was confirmed by qRT-PCR. 
The expression of the mCherryFP gene, which is present in the vec-
tor, was used as a marker to identify the transfected ES colonies, which 
were transferred to 24-well plates and grown in medium with or with-
out LIF and MEFs for 5 days. Differentiated and undifferentiated ES 
cells were subsequently subjected to immunofluorescence staining of 
Nanog, Oct4, and SSEA-1 pluripotency antibodies, as described by the 
manufacturer’s instructions (Abcam).
Results and Discussion
Construction of an episome vector expressing the L1 
retrotransposon that allows GFP expression and G418 drug 
selection
As an insertional mutagenesis system, we constructed an S/MAR-
based L1 retrotransposon vector that consisted of a full-length active 
human L1 gene (L1RP) under the control of the cytomegalovirus 
(CMV) immediate early promoter, which has been reported to be 
transcriptionally active in a variety of undifferentiated mouse ES cells 
[14]. The 3’-UTR of the L1 gene harbors a visual GFP marker disrupted 
by 960bp of a γ-globin intron in an antisense orientation (Figure 1A). 
GFP is co-transcribed as a single fusion transcript due to the presence 
of the splicing sites in the intron sequences. This arrangement ensures 
that GFP expression occurs only after L1 mobilization or insertional 
mutagenesis i.e., after L1 expression, γ-globin intron splicing, reverse 
transcription, and integration of the L1 copy into the genomic 
DNA (Figure 1B). Therefore, no GFP reporter is expressed unless 
the newly synthesized L1 is integrated into a new genomic location, 
and observation of the expression of GFP under a UV light would 
allow us to detect a real-time L1 disruptional event in living ES cells 
without cell staining (Figure 1C). In addition, this vector also contains 
a neomycin resistance gene that can be used to select transfected ES 
clones. To ensure the stability and the integrity of this vector, a DNA 
fragment containing scaffold/matrix attachment regions (S/MARs) 
was added to the vector backbone. We have recently shown that the 
inclusion of S/MARs effectively maintains a single copy of the vector in 
cells throughout multiple rounds of cell division without undergoing 
epigenetic silencing by DNA methylation or a loss of the vector, even in 
the absence of G418 drug selection [13]. We introduced the S/MAR-L1-
GFP vector into mouse ES cells using nucleofection and, as determined 
by a fluorescence-activated cell sorting (FACS) analysis, achieved 2.4 ± 
0.26% GFP-positive cells, compared to 1.7 ± 0.12% GFP-positive cells 
using an EBNA-based RP99-L1-GFP vector carrying the same L1-GFP 
expression cassette. This high level of retrotransposition from S/MAR-
L1-GFP in ES cells is consistent with our previous studies [13], which 
demonstrated that the S/MAR-based L1 vector system increases the L1 
retrotransposition events during the culturing of human somatic cells.
Selection of disrupted genes in ES clones that fail to 
differentiate 
Undifferentiated ES cells contain reduced levels of global DNA 
methylation and active or open chromatin structures [15]. Under 
these conditions, the expression of the L1 retrotransposon results in 
the random insertion of a copy into the host genome. When L1 inserts 
into a gene, the protein encoded by that gene should be truncated 
and its function disrupted [16]. If the disrupted gene is essential for 
self-renewal and differentiation, then the ES cells may remain in an 
undifferentiated state even when subjected to differentiation-inducing 
conditions, such as the absence of LIF. Interestingly, L1 is rarely 
expressed in terminally differentiated cells. This approach should allow 
us to discover the potential genes that regulate ES cell renewal and 
differentiation. 
To test this approach, we transfected mouse ES cells derived from 
C57BL/6 mice; the approach used to isolate the candidate gene in the 
ES cells is shown in Figure 2. An S/MAR-based L1 retrotransposition 
(pS/MAR-L1-GFP) was transfected into ES cells using the Amaxa 
ES Nucleofector Kit and was grown on a layer of feeder fibroblast 
cells (MEFs). The G418-resistant clonies were selected with 175 
µg/ml neomycin for 7 days. Using fluorescence microscopy, each 
G418-resistant GFP-positive colony was picked individually and 
transferred to a 24-well plate seeded with MEF feeder layers. It should 
be emphasized that the GFP expression from the L1 vector occurs 
only after the successful insertion of the L1 copy into a new genomic 
location. In this study, we screened approximately 50 ES cell clones that 
displayed resistance to G418 in a single 10-cm plate. Approximately 
85% of the G418-resistant clones we examined did not show any GFP 
Figure 1: The L1 retrotransposon vector. (A) Schematic diagrams of the S/MAR-based L1 episomal cassettes (pS/MAR-L1-GFP) used for generating loss-of-function 
genes in ES cells. The vector arrangement ensures that GFP will become functional only after the successful insertion of an L1 copy into a gene. (B) PCR analysis of ES 
cell genomic DNA. The 1.49 kb PCR product represents the original L1 vector harboring the intron-containing GFP. The 531 bp PCR product, a diagnostic for the loss of 
the intron, indicates a gene disruption. Positive, 10 ng vector; Negative, no template; Marker, 1 kb-plus DNA marker; U, undifferentiated; D, differentiated ES clone. (C) 
A representative result of ES clone screening by GFP expression.
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fluorescence while maintaining the L1 vector; thus, not all of the ES 
cells undergo the insertion of L1 integration event. This suggests that 
the efficiency of the S/MAR-based insertional mutagenesis in ES cells 
is relative low in comparison to standard retroviral-based insertional 
vector approaches in which at least 10 insertional colonies have been 
reported in a single 10-cm dish [17]. In total, we identified only 9 GFP-
positive, G418-resistant clones in a 10-cm plate. Each GFP-positive 
colony was maintained as an independent clone in culturing MEFs in 
replicates where one set was cryopreserved and the others were used to 
determine whether the cells retained the ability to differentiate. ES cells 
undergo in vitro cell differentiation in the absence of LIF and MEFs.
The selected GFP clones were grown in the absence of LIF and 
MEF feeder cells for 5 to 6 days, either in adherent monoculture or 
in suspension culture, for the formation of embryoid bodies (EBs). 
If a gene putatively involved in differentiation is disrupted by the 
L1 insertion, these cells will lose the ability to differentiate into the 
EBs. For comparison, untransformed wild-type ES cells or pEGFP-
N1-expressing ES cells were used as the controls. The failure of the 
ES clones to differentiate was simply assessed by a morphological 
analysis using an inverted phase contrast microscope, thus narrowing 
down the number of potential ES clones into a manageable number 
for further genetic and phenotypic analysis. In the absence of LIF 
and MEFs, we found that 4 out of 9 individual GFP-positive cells 
remained undifferentiated. In contrast, the other five GFP-positive 
cells became differentiated within 4 days, similar to the wild-type ES 
cells without LIF and MEFs; we reasoned that these cases might be 
Figure 2: Flow chart for the experimental procedures.
Figure 3: Verifying the loss of the cell differentiation ability. (A) Inverted microscopic image of ES cells harboring an L1 insertion. Normal ES cells and Actr6-disrupted ES 
cells (A2 clone) were used as the positive and negative controls, respectively, for cell differentiation. Tollip-disrupted ES cells (B1 clone) completely failed to differentiate in the 
absence of LIF even after 4 weeks. Plus, presence; minus, absence of LIF and MEFs. (B) The identification of disrupted Actr6 and Tollip genes by inverse PCR. The disrupted 
sites from the L1 insertions and their positions with regard to the exon-intron organization of the genes are shown. (C) Validation of the Tollip mutation after treatment with Tollip-
specific shRNAs in the normal ES cells. Immunofluorescence staining of the undifferentiated versus the differentiated Tollip-knockdown ES cells are shown. Note the loss of 
differentiation without LIF/MEFs. (D) Quantification of endogenous Oct4, Nanog and GAPDH (internal control). qRT-PCR analysis performed in the presence or absence of LIF/
MEFs after Tollip-specific shRNA transfection in the wild-type ES cells. Plus, presence; minus, absence of LIF and MEFs.
Citation: Lee SH, Rangasamy D (2012) LINE-1 Based Insertional Mutagenesis Screens to Identify Genes Involved in Embryonic Stem Cell 
Differentiation. J Stem Cell Res Ther 2:117. doi:10.4172/2157-7633.1000117
Page 5 of 6
Volume 2 • Issue 1 • 1000117
J Stem Cell Res Ther
ISSN:2157-7633  JSCRT, an open access journal 
due to the insertion of L1 into genes or noncoding intergenic regions 
that are not essential for ES cell differentiation. In fact, analyzing the 
L1 integration site of one of the GFP-positive ES differentiated cells 
showed that L1 was located in the intergenic region of chromosome 11 
(112835881-112836059), a site with no genes nearby. A blast analysis 
of this genomic sequence showed that this region contained only a 
hypothetical protein, LOC72386, which is located 70 kb downstream 
of the L1 integration site (data not shown). 
The intensity of the GFP fluorescence of the ES clone and the 
degree of cell differentiation upon ES cell differentiation varied 
among the candidate clones. One of the ES clones (named A8) that 
showed weak GFP expression was found to exhibit a delayed partial 
cell differentiation, whereas the other clones (named A2, B1 and 
B9) completely failed to undergo any cell differentiation even after 4 
weeks of culturing in the absence of LIF (Figure 3A). To determine 
whether the defective ES cell clone was a result of the L1 insertion, we 
conducted a PCR-based analysis to confirm the presence of spliced 
GFP in these cells. The genomic DNA isolated from the defective ES 
clones was subjected to a GFP-specific PCR assay, as shown in Figure 
1B. An oligonucleotide primer specific for the GFP gene was used to 
determine whether the intron had been removed by γ-splicing during 
the L1 insertional events; the unspliced PCR product is 1491 bp rather 
than the expected 531 bp in the case of a successful L1 insertion. This 
simple strategy allowed us to confirm the presence of retrotransposed 
L1 insertions in the defective ES cell colonies.
Identification of the disrupted candidate genes in the ES 
clones 
To identify the disrupted genes in the ES clone, we used an inverse 
PCR analysis. Approximately 1 µg genomic DNA was isolated from 
the candidate ES cell clones and was digested with SspI followed by 
self-ligation with T4 DNA ligase. The resulting products were subjected 
to inverse PCR amplification using a primer complementary to the 
3’-UTR of the L1 sequence (forward primer) and another primer 
corresponding to the downstream region of the GFP sequence (reverse 
primer). As the sequence of human L1 is completely different from the 
mouse version, the inverse primers should specifically amplify only 
the integrated L1 insert. The PCR product was subsequently cloned 
into the TOPO-XL vector for DNA sequencing, which enabled us to 
identify the flanking sequences of the disrupted genes in the genomic 
DNA using the UCSC mouse genome browser (Figure 3B). Using this 
strategy, we identified the L1 integration sites and their corresponding 
disrupted genes for the candidate ES clones that displayed the loss of 
ability to differentiate in the absence of LIF and MEFs, as illustrated in 
Table 1. Although L1 normally results in a single insertion event, we 
found that it occasionally integrates into multiple sites of the genome.
Two of the identified genes resulting from the L1 insertions are 
Arp6-actin-related protein (Actr6) (A2) and GATA-binding protein 
4 (Gata4) (B9), which were previously shown to be necessary for 
ES cell differentiation. The Arp6 actin-related protein is a subunit 
of chromatin-remodeling factor, Tip60. Using high-throughput 
RNAi screening, Tip60 was recently shown to be essential for ES 
cell development through its functional overlap with Nanog [18]. 
Depletion of Tip60 was also found to reduce the levels of the cell-cycle 
regulators and metabolic genes required for ES cell division. Gata4 is 
one of the well-characterised transcription factors that is expressed in 
ES cells [19]. The L1 integration site in the third ES clone (A8), which 
exhibited delayed partial cell differentiation, matched three different 
sites; one insertion was identified as the intron of the tripartite motif-
containing 59 protein (TRIM59), and the remaining two sites occurred 
in the intergenic regions of chromosomes 7 and 11. Because this ES 
clone (A8) contains more than one L1 integration site, we did not 
pursue it further because the complexity and heterogeneity of multiple 
disruptions make them difficult to analyze. Interestingly, the L1 
insertion site in the fourth clone (B1) is a candidate gene that has never 
been reported to play a role in ES cell differentiation. The L1 insertion is 
located in exon 2 of the Toll-interacting protein (Tollip) gene. Although 
little is known about this gene in ES cell differentiation, Tollip is known 
to interact with Toll-like receptors (TLR) to inhibit TLR-mediated 
signaling pathways [20,21]. In addition, Tollip plays a key role in cell-
cell signaling, inflammatory cytokine production, and intracellular 
signaling pathways. Thus, further studies are required to delineate the 
exact function of this gene in stem cell differentiation. Nevertheless, 
the data presented here suggest that the L1 retrotransposon system 
can identify previously unknown genes involved in mouse ES cell 
differentiation.
Confirming the function of the disrupted genes in ES cell 
differentiation 
To confirm whether ES cell differentiation is indeed dependent on 
the function of the identified genes, we resorted to the use of shRNAs 
against each gene in wild-type ES cells, followed by staining with alkaline 
phosphatase (AP), which is known to be expressed at a high level in the 
cell membrane of undifferentiated ES cells [22]. As the expression of AP 
is often used as an indicator of the undifferentiated state of ES cells, we 
utilized this simple staining approach to validate the undifferentiated 
state of the ES cell clones. Using wild-type ES cells, we introduced three 
Tollip-specific prevalidated shRNAs independently into the cells and, 
as determined by qRT-PCR analysis, achieved 78 ± 6% knockdown 
efficiency of the Tollip gene compared to the wild-type ES cells (data 
not shown). The ES cells transfected with each shRNA against the 
Tollip gene were cultured in the presence and absence of LIF, followed 
by AP staining. In this assay, the Actr6 mutant ES cell (clone A2) was 
used as a known positive gene. The Tollip-knockdown ES cells showed 
high levels of AP activity in the presence or absence of LIF and MEFs 
similar to the expression pattern observed with other undifferentiated 
ES cell markers [23,24], including Oct4, Nanog, and SSEA-1 (Figure 
3C). Additionally, we employed a semi-quantitative RT-PCR analysis 
to evaluate whether the ES cell markers showed similar expression 
levels in response to the removal of LIF. The expression levels of the 
Nanog and Oct4 markers remained similar in both the presence and 
Trapped ES clone Accession L1 integrated site Gene Gene product
A2 NM_025914.2 Chr.10qC1: 89189558 Actr6 ARP6 actin-related protein
B9 NM_008092.3 Chr.14qD1:63819210 GATA4 GATA binding protein 4
A8 NM_025863.3 Chr.3qE1: 68838551 TRIM59 Tripartite motif containing 59*
B1 NM_023764.3 Chr.7qF5: 149067490 Tollip Toll-interacting protein
*contained three L1 integration sites
Table 1: Genes identified by L1 insertional mutagenesis that displayed defect in ES cell differentiation.
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absence of LIF, suggesting that the ES cell with defective the Tollip 
gene do not have the ability to differentiate (Figure 3D). As expected, 
under the standard in vitro-directed cell differentiation conditions, the 
Tollip-knockdown ES cells failed to undergo cell differentiation in the 
absence of LIF. Taken together, these results suggest that Tollip plays 
an essential role in ES cell differentiation.
At present, little is known about the function of Tollip or its 
regulatory pathways that direct stem cell differentiation. Tollip is 
known to act in the immune response to invading pathogens by 
controlling IRAK phosphorylation in the TLR and IL-1R signaling 
pathways [20]. Tollip is also known to suppress TLR-mediated NF-κB 
activity. A recent study in mesenchymal stem cells suggests that TLR4, 
which is the receptor for Tollip, inhibits the activation of transcription 
factor STAT3 (signal transducer and activator of transcription 3) and 
thereby exerts deleterious effects on stem cell proliferation [25]. As 
STAT3 mediates self-renewal and the maintenance of pluripotency in 
the absence of LIF, it is essential for ES cell differentiation [26]. Several 
molecules, such as Zfp57, GABP and β-catenin, have been identified as 
the factors involved in the LIF/STAT3 pathway. Thus, it is tempting to 
speculate that the disruption of Tollip may inactivate STAT3 through 
TLR receptors, resulting in the lack of proper ES cell differentiation. 
However, further studies are required to delineate the exact molecular 
mechanisms of this gene. Nonetheless, the data presented in this study 
show that the L1 retrotransposon approach can identify both novel 
genes and known genes that regulate ES cell differentiation. 
Conclusion
Embryonic stem cells have a relatively stable genome and are highly 
amenable to loss-of-function genetic screens. The recent development 
of the L1 retrotransposon approach offers an efficient and highly 
versatile alternative for achieving the complete disruption of gene 
function. The ease of using this insertional mutagen and the simplicity 
of identifying the cells with disrupted genes by GFP expression make 
this L1 vector a promising tool to identify the genes that play roles in 
cell growth, morphology, differentiation and proliferation. Given that 
ES cells and other stem cells share many similarities, including the 
ability to self-renew, pluripotency and virtually identical chromatin 
states, this system can also be applied to identify critical genes in other 
stem cells, such as muscle stem cells, pluripotential stem cells or cancer 
stem cells.
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